Literature DB >> 32160194

Interactive molecular dynamics in virtual reality for accurate flexible protein-ligand docking.

Helen M Deeks1,2,3, Rebecca K Walters1,2,3, Stephanie R Hare3, Michael B O'Connor1,2,3, Adrian J Mulholland3, David R Glowacki1,2,3.   

Abstract

Simulating drug binding and unbinding is a challenge, as the rugged energy landscapes that separate bound and unbound states require extensive sampling that consumes significant computational resources. Here, we describe the use of interactive molecular dynamics in virtual reality (iMD-VR) as an accurate low-cost strategy for flexible protein-ligand docking. We outline an experimental protocol which enables expert iMD-VR users to guide ligands into and out of the binding pockets of trypsin, neuraminidase, and HIV-1 protease, and recreate their respective crystallographic protein-ligand binding poses within 5-10 minutes. Following a brief training phase, our studies shown that iMD-VR novices were able to generate unbinding and rebinding pathways on similar timescales as iMD-VR experts, with the majority able to recover binding poses within 2.15 Å RMSD of the crystallographic binding pose. These results indicate that iMD-VR affords sufficient control for users to carry out the detailed atomic manipulations required to dock flexible ligands into dynamic enzyme active sites and recover crystallographic poses, offering an interesting new approach for simulating drug docking and generating binding hypotheses.

Entities:  

Year:  2020        PMID: 32160194      PMCID: PMC7065745          DOI: 10.1371/journal.pone.0228461

Source DB:  PubMed          Journal:  PLoS One        ISSN: 1932-6203            Impact factor:   3.240


  55 in total

1.  FAST Conformational Searches by Balancing Exploration/Exploitation Trade-Offs.

Authors:  Maxwell I Zimmerman; Gregory R Bowman
Journal:  J Chem Theory Comput       Date:  2015-11-20       Impact factor: 6.006

2.  Finite temperature string method for the study of rare events.

Authors:  Weinan E; Weiqing Ren; Eric Vanden-Eijnden
Journal:  J Phys Chem B       Date:  2005-04-14       Impact factor: 2.991

Review 3.  Molecular dynamics in drug design.

Authors:  Hongtao Zhao; Amedeo Caflisch
Journal:  Eur J Med Chem       Date:  2014-08-04       Impact factor: 6.514

Review 4.  Protein structure-based drug design: from docking to molecular dynamics.

Authors:  Paweł Śledź; Amedeo Caflisch
Journal:  Curr Opin Struct Biol       Date:  2017-11-14       Impact factor: 6.809

5.  Energetic basis for drug resistance of HIV-1 protease mutants against amprenavir.

Authors:  Parimal Kar; Volker Knecht
Journal:  J Comput Aided Mol Des       Date:  2012-02-14       Impact factor: 3.686

6.  Binding kinetics of darunavir to human immunodeficiency virus type 1 protease explain the potent antiviral activity and high genetic barrier.

Authors:  Inge Dierynck; Mieke De Wit; Emmanuel Gustin; Inge Keuleers; Johan Vandersmissen; Sabine Hallenberger; Kurt Hertogs
Journal:  J Virol       Date:  2007-10-10       Impact factor: 5.103

7.  Computational studies of darunavir into HIV-1 protease and DMPC bilayer: necessary conditions for effective binding and the role of the flaps.

Authors:  Georgios Leonis; Żaneta Czyżnikowska; Grigorios Megariotis; Heribert Reis; Manthos G Papadopoulos
Journal:  J Chem Inf Model       Date:  2012-05-30       Impact factor: 4.956

8.  The Role of Neuraminidase Inhibitors in the Treatment and Prevention of Influenza.

Authors:  Naem Shahrour
Journal:  J Biomed Biotechnol       Date:  2001

9.  Computational assay of H7N9 influenza neuraminidase reveals R292K mutation reduces drug binding affinity.

Authors:  Christopher J Woods; Maturos Malaisree; Ben Long; Simon McIntosh-Smith; Adrian J Mulholland
Journal:  Sci Rep       Date:  2013-12-20       Impact factor: 4.379

10.  Revealing origin of decrease in potency of darunavir and amprenavir against HIV-2 relative to HIV-1 protease by molecular dynamics simulations.

Authors:  Jianzhong Chen; Zhiqiang Liang; Wei Wang; Changhong Yi; Shaolong Zhang; Qinggang Zhang
Journal:  Sci Rep       Date:  2014-11-03       Impact factor: 4.379

View more
  3 in total

1.  Group VR experiences can produce ego attenuation and connectedness comparable to psychedelics.

Authors:  David R Glowacki; Rhoslyn Roebuck Williams; Mark D Wonnacott; Olivia M Maynard; Rachel Freire; James E Pike; Mike Chatziapostolou
Journal:  Sci Rep       Date:  2022-05-30       Impact factor: 4.996

2.  Interactive Molecular Dynamics in Virtual Reality Is an Effective Tool for Flexible Substrate and Inhibitor Docking to the SARS-CoV-2 Main Protease.

Authors:  Helen M Deeks; Rebecca K Walters; Jonathan Barnoud; David R Glowacki; Adrian J Mulholland
Journal:  J Chem Inf Model       Date:  2020-11-11       Impact factor: 4.956

Review 3.  Open-Source Browser-Based Tools for Structure-Based Computer-Aided Drug Discovery.

Authors:  Ann Wang; Jacob D Durrant
Journal:  Molecules       Date:  2022-07-20       Impact factor: 4.927

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.